Pharma Journalist -

Vifor Fresenius Medical Care Renal Pharma (VFMCRP) announced the Therapeutic Goods Administration (TGA) in Australia has approved Tavneos in combination with a rituximab or…
Read More...

Forxiga (dapagliflozin) has been approved in the European Union to extend the indication for heart failure (HF) with reduced ejection fraction (HFrEF) to cover patients across the full…
Read More...

Aldeyra Therapeutics, Inc. announced that the U.S. Food and Drug Administration (FDA) has accepted the New Drug Application (NDA) for topical ocular reproxalap, a first-in-class…
Read More...

Genenta Science, a clinical-stage biotechnology company engaged in the development of hematopoietic stem progenitor cell immuno-gene therapy for cancer, has entered into a development…
Read More...

Healthcare continues to face crippling staff shortages, while communities are left underserved, and the national mental health crisis persists. Providers are battling to meet…
Read More...

Biogen Inc. and Sage Therapeutics, Inc. announced the U.S. Food and Drug Administration (FDA) has accepted the filing of a New Drug Application (NDA) for zuranolone in the treatment of…
Read More...

Sensei Biotherapeutics, Inc., an immuno-oncology company focused on the discovery and development of next-generation therapeutics for cancer patients, announced that it has signed a…
Read More...

Ultima Genomics, Inc. and 10x Genomics today announced a collaboration to integrate use of the 10x Genomics Chromium Single Cell Gene Expression solutions with Ultima's advanced…
Read More...

Sandoz, a global leader in off-patent (generic and biosimilar) medicines, announced that the US Food and Drug Administration (FDA) has accepted its Biologics License Application (BLA)…
Read More...

Atreca, Inc., a clinical-stage biotechnology company focused on developing novel therapeutics generated through a unique discovery platform based on interrogation of the active human…
Read More...